Given the high prevalence of fatty liver in diabetic patients (estimated at 5570%), initiating or switching to a GLP-1 agonist addresses both conditions simultaneously
They do not treat, prevent, diagnose, or cure any disease , as these are attributes of medicines, according to European Directive 2004/27/EC of 31 March, issued by the Council and the European Parliament on medicinal products
No warranty, express or implied, is made regarding the accuracy, completeness, or currentness of information presented
[14] Patients experiencing inadequate results with semaglutide should schedule a comprehensive review with their healthcare provider
A study involving treatment up to 104 or 117 weeks in 134 patients with T2DM showed EX microspheres-nave patients experienced weight reductions of -2.7 kg (116)
Resources like semaglutide with B12 explain when and how these combinations work best